The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis
Abstract
Fibroblast activation protein (FAPalpha) is a member of the cell surface dipeptidyl peptidase (DPP) family of serine proteases. In its dimer form, FAPalpha exhibits gelatinase, collagenase, and DPP activity in vitro. Reactive fibroblasts in healing wounds and stromal fibroblasts associated with epithelial tumors express FAPalpha. Idiopathic pulmonary fibrosis (IPF) is a disease of the lung characterized by progressive fibrosis with no clear etiology or molecular marker for disease activity. Recently, it has been shown that fibroblast FAPalpha expression is induced in liver cirrhosis, with an expression pattern distinct from alpha-smooth muscle actin (alpha-SMA). In this study, we determine whether FAPalpha expression is selectively induced in areas of ongoing tissue remodeling characterized by fibroblast foci in IPF. Human lung tissue was obtained from patients with IPF, centrilobular emphysema, and normal lung. Immunohistochemical studies were performed using anti-FAPalpha antibody and antibodies against alpha-SMA and CD26 (DPPIV), another member of the DPP family. We found that FAPalpha was not expressed in normal human lung tissue or tissue with evidence of centriacinar emphysema, but was induced in all patients with IPF and With a pattern distinct from that of CD26 found primarily on hyperplastic alveolar epithelium. Specifically, FAPalpha was detected in fibroblast foci and in fibrotic interstitium and not in the interstitium of adjacent architecturally normal lung. Alveolar/airway epithelium and vascular smooth muscle did not express FAPalpha. This is the first report of FAPalpha expression in IPF and our results suggest that FAPalpha is selectively induced in fibrotic foci, but not in normal or emphysematous lung. Future studies will address whether FAPalpha may be used as a marker for disease activity in IPF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FAP is expressed exclusively in fibrotic loci in the lungs of patients with IPF59”
From A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial (2025) · cites this paper as [59]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.103 · Cited by 2,269
Transforming growth factor beta
Roberts, A. B., & Sporn, M. B. (2011) · SpringerReference · doi:10.1007/springerreference_39918 · Cited by 1,945
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,807
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Self-citationIredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Sappino, A. P., Schürch, W., & Gabbiani, G. (1990) · PubMed · Cited by 833
Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix
ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696
Mechanisms of Myofibroblast Activity and Phenotypic Modulation
Serini, G., & Gabbiani, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4543 · Cited by 592
Park, J. E., Lenter, M., Zimmermann, R., Garin‐Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 591
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–206 of 206
Kimura, T., Honma, K., Nakanishi, K., Maniwa, T., Shintani, Y., & Okami, J. (2026) · Surgery Today · doi:10.1007/s00595-026-03404-y
Sun, L., Li, Z., Fang, D., Zheng, S., Deng, H., & Mu, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1884620
Önner, H., Abidin, K., Halil, O., Zengin, D. D., Burcu, Y., Dilek, E., Recai, E., Baykal, T., Önder, E. O., Farise, Y., et al. (2026) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2026.500348
Hasan, O., Abidin, K., Halil, O., Zengin, D. D., Burcu, Y., Dilek, E., Recai, E., Baykal, T., Önder, E. O., Farise, Y., et al. (2026) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2026.500348
Advances in imaging for systemic sclerosis
Lescoat, A., Ross, L., Bergmann, C., McMahan, Z. H., Galdo, F. D., Mogensen, M., Agarwal, P. P., Santiago, T., Schett, G. A., Luca, G. D. D., et al. (2026) · Lara D. Veeken · doi:10.1093/rheumatology/keag390
BindingDB (2014) · UC San Diego · doi:10.7270/q2kp83j7
Metadata
- Authors
- Acharya, P. S., Zukas, A., Chandan, V., Katzenstein, A.-L. A., & Puré, E.
- Affiliations
- The Wistar Institute (US)
- SUNY Upstate Medical University (US)
- Corresponding author
- Acharya, Pinak S.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 37
- Issue
- 3
- Pages
- 352-360
- ISSN
- 0046-8177 (ISSN-L)
- OpenAlex
- W2018096662
- Cited by
- 204
- References
- 38
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 16 · 2023: 25 · 2022: 20 · 2021: 11 · 2020: 11 · 2019: 5 · 2018: 5 · 2017: 14 · 2016: 9 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 6
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Pathology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P50HL067663, P50-HL67663)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- fibroblast activation protein, idiopathic pulmonary fibrosis, serine protease, dipeptidyl peptidase, tissue remodeling, fibroblast foci, alpha-smooth muscle actin, CD26, emphysema, pulmonary fibrosis, disease markers
- MeSH terms
- Fibroblast Activation Protein Alpha, Antigens, Surface, Emphysema, Female, Fibroblasts, Humans, Immunoenzyme Techniques, Lung, Male, Membrane Proteins, Middle Aged, Endopeptidases, Pulmonary Fibrosis, Serine Endopeptidases, Gelatinases, Dipeptidyl Peptidase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review